Skip to main content

Table 2 Clinical Laboratory Determinations

From: Study protocol: rationale and design of the community-based prospective cohort study of kidney function and diabetes in rural New Mexico, the COMPASS study

Screening tests

Additional tests in participants with CKD

Blood/Serum

Complete Blood Cell Count (including Hemoglobin and Hematocrit)

Magnesium

Hemoglobin A1C

Lead

C-peptide

Parathyroid Hormone

Insulin

Vitamin D, 25-Hydroxy

Full non-fasting lipid panel

 

Renal Function Panel: sodium, potassium, chloride, carbon dioxide, glucose (random/non-fasting), blood urea nitrogen, creatinine, albumin, phosphorus

 

Uric Acid

 

High Sensitivity C-reactive Protein

 

Cystatin C

 

Βeta 2 Microglobulin

 

Urine

Automated Urinalysis

Urine Urea Nitrogen

Urine Creatinine

Urine Electrolytes: Sodium, Potassium, Chloride, Calcium, Phosphorus, and Magnesium

Urine Albumin and Total Protein

Urine Uric Acid